We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 3

1.
Figure 2.

Figure 2. From: Low Expression of TBX4 Predicts Poor Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma.

Kaplan–Meier survival curves show that TBX4-low expression PDAC patients had a shorter survival than those with TBX4-high expression. The difference is statistically significant based on the log-rank test (P = 0.010).

Meijuan Zong, et al. Int J Mol Sci. 2011;12(8):4953-4963.
2.
Figure 1.

Figure 1. From: Low Expression of TBX4 Predicts Poor Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma.

Representative micrographs showing pancreatic ductal adenocarcinoma (PDAC) with high TBX4 expression with cytoplasmic and nuclear staining (A) and low TBX4 expression (B). Original magnification, ×400.

Meijuan Zong, et al. Int J Mol Sci. 2011;12(8):4953-4963.
3.
Figure 3.

Figure 3. From: Low Expression of TBX4 Predicts Poor Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma.

Methylation status of 18 CpG sites in the TBX4 promoter region (−1842 to −1626) were analyzed in 7 PDAC tissues (T1-7) (3 cases were defined as low level of TBX4 expression, and the other 4 cases were defined as high level of TBX4 expression) and adjacent normal pancreas tissues (N1-7) (A); Black, gray, and white squares represent complete methylation, partial methylation, and unmethylation status at each CpG site, respectively (B). Methylation status was frequently observed in both PDAC and adjacent normal pancreas tissues.

Meijuan Zong, et al. Int J Mol Sci. 2011;12(8):4953-4963.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk